Interactions Between Pharmaceutical Companies and Patient Advocacy Groups in Japan: A Qualitative and Quantitative Interview Study
Ayaka Kikuchi, Asuka Hara, Akihiko Ozaki, Natsuya Sakata, Hiroaki Saito, Tetsuya Tanimoto, Hideki Maeda · 2025
Read Interactions Between Pharmaceutical Companies and Patient Advocacy Groups in Japan: A Qualitative and Quantitative Interview Study by Ayaka Kikuchi, Asuka Hara, Akihiko Ozaki, Natsuya Sakata, Hiroaki Saito, Tetsuya Tanimoto, Hideki Maeda (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12667415.txt.
Description
A peer-reviewed research article from Europe PMC (2025). PurposeIn Japan, the financial relationship between pharmaceutical companies and patient advocacy groups is considered to be weak; however, limited studies have examined this relationship. The financial relationship and issues surrounding the relationship between the two parties remain unclear.Patients and MethodsThis study investigated the relationship between Japanese patient support groups and pharmaceutical companies by interviewing 10 pharmaceutical companies and examining the underlying challenges. Conducted from 2022 to 2023, this research employed a qualitative and quantitative interview survey using a prospective study design.
Catalog record
| CREATOR | Ayaka Kikuchi, Asuka Hara, Akihiko Ozaki, Natsuya Sakata, Hiroaki Saito, Tetsuya Tanimoto, Hideki Maeda |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |